In vitro studies of colorectal cancer cells showed that treatment with CCL21 upregulated P-glycoprotein and NANOG/OCT4, which enhanced chemotherapy resistance and promoted cell survival and tumorsphere formation, respectively 159. Here, POU5F1 is linked to colorectal cancer.